BindingDB

The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 2.8M data for 1.2M Compounds and 9.2K Targets. Of those, 1,346K data for 622K Compounds and 4.5K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

Donate Now

Advanced Search

8 articles for thisTarget

The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
Rational design of novel, potent small molecule pan-selectin antagonists.EBI
Revotar Biopharmaceuticals
Novel synthetic inhibitors of selectin-mediated cell adhesion: synthesis of 1,6-bis[3-(3-carboxymethylphenyl)-4-(2-alpha-D- mannopyranosyloxy)phenyl]hexane (TBC1269).EBI
Texas Biotechnology
Studies on selectin blockers. 7. Structure-activity relationships of sialyl Lewis X mimetics based on modified Ser-Glu dipeptides.EBI
Kanebo
Studies on selectin blocker. 1. Structure-activity relationships of sialyl Lewis X analogs.EBI
Institute Of Cancer Research
Studies on selectin blockers. 2. Novel selectin blocker as potential therapeutics for inflammatory disorders.EBI
New Drug Research Laboratory
A solid-phase synthesis for beta-turn mimetics of sialyl Lewis X.EBI
Nippon Organon K.K.
Aryl C-glycosides: physiologically stable glycomimetics of sialyl Lewis X.EBI
Sankyo
Selectin-ligand interactions revealed by molecular dynamics simulation in solution.EBI
Kanebo